细胞治疗的现状
摘要
细胞治疗作为免疫治疗的措施之一，已经成为治疗恶性血液病及异基因造血干细胞移植患者的新选择。目前血液病患者细胞治疗措施包括树突细胞和细胞因子诱导的杀伤细胞、病毒特异性T细胞和间充质干细胞输注等。本文就细胞治疗的研究进展作一综述。
出处
《国际输血及血液学杂志》
CAS
2011年第5期302-303,共2页
International Journal of Blood Transfusion and Hematology
基金
江苏高校优势学科建设工程资助项目
新药研究开发关键技术研究项目（2009ZX09503）
参考文献12
-
1Baker J, Verneris M, Ito M, et al. Expansion of cytolytic CD8 + natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon γ production. Blood, 2001,97(10):2923-2931.
-
2Franceschettia M, Pievania A, Borleri G, et al. Cytokine- induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes. Exp Hematol, 2009, 37 (5) : 616-628.
-
3Introna M, Borleri G, Conti E, et al. Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study. Haematologica, 2007, 92(7) : 952-959.
-
4Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J Immunother, 2001, 24(6) :502- 510.
-
5Seggewiss R and Einsele H. allogeneic transplantation and Immune reconstitution after expanding options for immunomodulation., an update. Blood, 2010, 115 (19) : 3861- 3868.
-
6Feuchtinger T, Opherk K, Bethge W, et al. Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory eytomegalovirus disease or reactivation after haploidentieal and matched unrelated stem cell transplantation. Blood, 2010, 116 (20) : 4360-4367.
-
7Moosmann A, Bigalke I, Tischer J, et al. Effective and long- term control of EBV PTLD after transfer of peptide-selected T cells. Blood, 2010,115(14) :2960-2970.
-
8Leen A, Myers G, Sili U, et al. Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals. Nat Med, 2006, 12(10): 1160-1166.
-
9Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 2006,8(4) : 315-317.
-
10Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus- host disease: a phase Ⅱ study. Lancet, 2008, 371(9624): 1579- 1586.
-
1曾春林,肖序仁.造血干细胞输注诱导免疫耐受的现状及展望[J].医学研究杂志,2008,37(10):10-12.
-
2宫立众,孙士红,程天民,粟永萍,罗成基,郭朝华.骨髓间质干细胞输注对外周血干细胞移植造血恢复的影响[J].中国病理生理杂志,2002,18(11):1349-1352. 被引量：3
-
3侯瑞琴,王婧,孔圆,陈育红,黄晓军,曾洋,葛健,刘全华,赵春华,刘开彦.单倍体相合造血干细胞移植联合间充质干细胞输注对患者造血微环境的影响[J].中国实验血液学杂志,2010,18(1):155-160. 被引量：11
-
4黄雅静,孙琪云,刘丽辉,范传波,胡恺勋,边莉,郭梅,艾辉胜.体外皮肤移植和TUNEL实验评价猕猴间充质干细胞输注对细胞免疫的影响[J].第二军医大学学报,2006,27(5):465-469.
-
5周和平,金振晓,顾春虎,刘金诚,俞世强,崔勤,易定华.供者骨髓基质干细胞输注延长大鼠移植心存活时间的探讨[J].中华器官移植杂志,2008,29(6):328-330.
-
6孙建军,曲青山,王振璞,陈国勇,苗书斋,蔡文利,邢利.骨髓干细胞输注诱导大鼠肾移植免疫耐受中Foxp3的表达机制探讨[J].医药论坛杂志,2009,30(18):58-60.
-
7陆英,张祥忠,刘相富,李芳,林东军.间充质干细胞输注对移植物抗宿主病中不同受损器官的治疗效果[J].中国组织工程研究,2014,18(23):3676-3681. 被引量：6
-
8邓春阳,冯建勋,张海英,陈庭芳,李静.羊水干细胞诱导肾移植免疫耐受及对氧化应激的影响[J].中国组织工程研究,2015,19(45):7342-7349. 被引量：1
-
9章爱梅,章爱华,刘峰之,孙福廷,张培良.间充质干细胞在骨折病人创伤修复中的应用研究[J].中外医疗,2016,35(13):63-64.
-
10刘丽辉,孙琪云,胡锴勋,范传波,黄雅静,郭梅,孙昭,赵春华,艾辉胜.猕猴异体间充质干细胞输注安全性评价及异体存活分析[J].第二军医大学学报,2005,26(3):263-266.
